Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT05114980
NA

Parathyroid Allotransplantation in Medically Refractory Hypoparathyroidism

Sponsor: University of Alabama at Birmingham

View on ClinicalTrials.gov

Summary

Options for treatment of severe, refractory hypocalcemia are limited for the thousands of patients in the United States who suffer from hypoparathyroidism. Parathyroid allotransplantation is an emerging treatment that provides hope for these individuals. Currently, this therapy has only been successfully provided by a few centers in the world. In the UAB PATH trial, we propose to become one of the few centers worldwide to successfully achieve parathyroid allotransplantation in transplant-naïve patients.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

5

Start Date

2027-07

Completion Date

2030-01

Last Updated

2025-07-11

Healthy Volunteers

No

Interventions

PROCEDURE

Parathyroid Allotransplant

Patients that meet inclusion criteria and are enrolled in the trial will undergo parathyroid allotransplantation

Locations (1)

University of Alabama at Birmingham

Birmingham, Alabama, United States